Global Meningococcal Vaccines Market Covid-19 Impact Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2031
-
23419
-
May 2023
-
162
-
-
This report was compiled by Correspondence Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
What Our Global Meningococcal Vaccines Market Report Offers?
Global Meningococcal Vaccines Market is the title of an upcoming report offered by MarketResearch.Biz. The Meningococcal Vaccines market report extensively covers market segmentation by product type, by end use, by end use industry, and by geography (APAC, North America, Europe, South America, and MEA) and potential Meningococcal Vaccines market drivers that the vendors are capitalizing on to sustain profitable growth. Furthermore, read about the latest key findings on the post-COVID-19 impact on the Meningococcal Vaccines market from this report.
“The global Meningococcal Vaccines market size is expected to be worth around US$ 18,039.70 million by 2031 from US$ 5,361.50 million in 2021, growing at a CAGR of 12.89% during the forecast period 2021 to 2031.”
It is complete with important statistics and other industry-relevant particulars, including factors expected to influence Meningococcal Vaccines market progress, drivers, restraints, opportunities, trends, sales reviews, landmark developments (existing and anticipated), SWOT analysis, as well as information on other potential revenue generation prospects in un explored areas of operation. The data collated by our analysts from both primary and secondary sources, are validated by data management solutions, and more importantly industry experts, to ensure genuine authenticity. The global Meningococcal Vaccines market report will encompass imminent threats or challenges from existing industry contenders, as well as potential new market entrants. Additionally, this dossier will also explore existing as well as foreseeable impacts of the on-going COVID-19 pandemic.
Impacts of the COVID-19 Pandemic:
Most industries across the world have been negatively impacted over the last few months. This can be attributed to significant disruptions experienced by their respective manufacturing and supply-chain operations as a result of various precautionary lockdowns, as well as other restrictions that were enforced by governing authorities across the globe. The same applies to the global Meningococcal Vaccines market. Moreover, consumer demand has also subsequently reduced as individuals are now more keen on eliminating non-essential expenses from their respective budgets as the general economic status of most individuals have been severely affected by this outbreak. These aforementioned elements are expected to burden the revenue trajectory of the global Meningococcal Vaccines market over the forecast timeline. However, as respective governing authorities begin to lift these enforced lockdowns, the global Meningococcal Vaccines market is expected to recover accordingly.
Who are the Major Meningococcal Vaccines Market's Key Players?
Key industry players profiled in this global Meningococcal Vaccines market include: Sanofi SA, Novartis International, GlaxoSmithKline plc, Pfizer Inc., Nuron Biotech, JN-International Medical Corporation, Serum Institute of India Ltd., Baxter International, and Biomed Pvt. Ltd
Segmentation of the Global Meningococcal Vaccines Market:
Meningococcal Vaccines Market, by Product Type
- Polysaccharide Vaccines
- Menomune
- Menuceuvax
- NmVas4
- Others
- Conjugate Vaccines
- Menactra
- Menveo
- NeisVac-C
- Nimenrix
- Meningitec
- Menjugate
- MenAfriVac
- NmVas4-DT
- Combination Vaccines
- MenHibrix
- Menitorix
- Men B Vaccines
- Bexero
- Trumenba
Meningococcal Vaccines Market, by End-User
- Retail Pharmacies
- Hospital Pharmacies
- Others
Meningococcal Vaccines Market, by End-use Industry
- Aerospace and Defence
- Automotive
- Consumer Electronics
- Healthcare
- Food and Beverages
- Energy and Utility
- Others (Including Telecom Manufacturing)
Meningococcal Vaccines Market, by Region
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- India
- China
- Japan
- Australia and New Zealand
- Rest of Asia Pacific
- Latin America
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Israel
- Rest of Middle East and Africa
What are the Key Factors Covered in this Meningococcal Vaccines Market Report?
- CAGR of the Meningococcal Vaccines market during the forecast period 2021-2031.
- Precise estimation of the Meningococcal Vaccines market size and its contribution to the parent market.
- Detailed information on factors that will drive Meningococcal Vaccines market growth during the next ten years.
- Accurate predictions on upcoming trends and changes in consumer behaviour.
- The growth of the Meningococcal Vaccines market across APAC, North America, Europe, South America, and MEA.
- A thorough analysis of the Meningococcal Vaccines market’s competitive landscape and detailed information on key Players.
- Comprehensive details of factors that will challenge the growth of Meningococcal Vaccines market vendors.
- Meningococcal Vaccines Market’s Opportunity Orbits
- Market Investment Feasibility Index
- PEST Analysis
- PORTER’S Five Force Analysis
- Drivers & Restraints Impact Analysis
- Marketing Strategy
- Product Life Cycle Analysis
- Value Chain Analysis
- Cost Structure Analysis
- Macro-economic Factors
[table_custom cagr=12.89% market_size=5,361.50Mn USD projection=18,039.70Mn USD]
- Polysaccharide Vaccines
-
-
- Sanofi SA
- Novartis International
- GlaxoSmithKline plc
- Pfizer Inc.
- Nuron Biotech
- JN-International Medical Corporation
- Serum Institute of India Ltd.
- Baxter International
- Biomed Pvt. Ltd